Last $8.10 USD
Change Today -0.01 / -0.12%
Volume 7.5K
As of 5:20 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

muscle pharm corp (MSLP) Key Developments

Muscle Pharm Corporation Enters into a Commercial Loan Agreement for $4,000,000 with ANB Bank

Effective February 24, 2015, Muscle Pharm Corporation entered into a Commercial Loan Agreement with ANB Bank, pursuant to which the company and ANB executed a Promissory Note, pursuant to which the company borrowed, from ANB, a principal amount of $4,000,000, subject to certain terms and conditions as further described in the Loan Documents. The Note matures on February 20, 2018. Loans made pursuant to Loan Agreement are secured by (i) a security interest in all of the company's inventory, (ii) all of the company's accounts receivable or other payments due, (iii) all the company' general intangible properties, including, but not limited to, tax refunds, intellectual property and customer lists, and (iv) 866,600 shares of the company's common stock currently held in the company's treasury, pursuant to the Security Agreement entered into by and between the company and ANB. The interest rate which shall accrue on the principal amount of the Note is 5.250% per annum.

MusclePharm Corporation Announces the Launch of Two New Energy Drinks, MusclePharm Energy Sport and Energy Sport Zero

MusclePharm Corporation announced the launch of two new energy drinks, MusclePharm Energy Sport and Energy Sport Zero, both will be previewed at the Arnold Sports Festival March 5-8, 2015 in Columbus, Ohio. MusclePharm Energy Sport will be available in two flavors, Original and Electric Lime, while the MusclePharm Energy Sport Zero will be available in Citrus Edge, Onyx Cherry, and Power Punch.

MusclePharm Corporation Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Maintains Earnings Guidance for the Full-Year 2014

MusclePharm Corporation reported unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, net sales increased 88.5% to $47.8 million from $25.3 million last year, primarily due to broadening distribution channels resulting in new customers, releasing new products, and development of strategic partnerships. Net income for the third quarter was $603,000, or $0.05 per diluted share, compared with a net loss of $3.9 million, or $0.47 per share, for the same period last year. Loss from operations was $4,537,455 compared to $4,872,780 a year ago. For the nine months, net income was $2.4 million, or $0.20 per diluted share, compared with a net loss of $13.7 million, or $2.07 per share, for the same period last year. Net sales increased 97% to $144.7 million from $73.4 million last year. Loss from operations was $2,976,893 compared to $8,335,192 a year ago. The company is maintaining its full-year revenue guidance for 2014 calling for net sales of approximately $185 to $195 million. The company is adjusting its earnings per share range to $0.20 to $0.22 per diluted share, in line with guidance issued at beginning of the year.

Muscle Pharm Corp. to Report Q3, 2014 Results on Nov 14, 2014

Muscle Pharm Corp. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Nov 14, 2014

Muscle Pharm Corp., Q3 2014 Earnings Call, Nov 17, 2014

Muscle Pharm Corp., Q3 2014 Earnings Call, Nov 17, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSLP:US $8.10 USD -0.01

MSLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natural Grocers by Vitamin Cottage Inc $28.75 USD -0.78
USANA Health Sciences Inc $100.96 USD -0.04
Vitamin Shoppe Inc $42.01 USD -0.61
View Industry Companies
 

Industry Analysis

MSLP

Industry Average

Valuation MSLP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MUSCLE PHARM CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.